The lack of any significant differences in cytokine or chemokine levels between acetate or mock-treated GPR43−/− mice confirmed that the presence of both, GPR43 and sufficient amounts of its agonist acetate, can prevent severe courses of sepsis in mice (Fig. 6b). This evidence concerns the gene FFAR2 and Sepsis.